Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaughan Williams

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
American Journal of Therapeutics|April 1, 1995
Antiarrhythmic Drug Development: Classification and its Impact on DevelopmentE.M. Vaughan Williams
Nursing Mirror|July 21, 1982
White coats everywhereA Vaughan-Williams
Journal of Cardiovascular Pharmacology|January 1, 1992
The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actionsE M Vaughan Williams
European Heart Journal|November 1, 1985
Delayed ventricular repolarization as an anti-arrhythmic principleE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1987
Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agentE M Vaughan Williams
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1975
Classification of antidysrhythmic drugsE M Vaughan Williams
Annals of the New York Academy of Sciences|January 1, 1984
DisopyramideE M Vaughan Williams
Journal of Clinical Pharmacology|April 1, 1984
A classification of antiarrhythmic actions reassessed after a decade of new drugsE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1991
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trialE M Vaughan Williams
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmiasE M Vaughan Williams
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Therapeutics|April 1, 1995
Antiarrhythmic Drug Development: Classification and its Impact on DevelopmentE.M. Vaughan Williams
Nursing Mirror|July 21, 1982
White coats everywhereA Vaughan-Williams
Journal of Cardiovascular Pharmacology|January 1, 1992
The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actionsE M Vaughan Williams
European Heart Journal|November 1, 1985
Delayed ventricular repolarization as an anti-arrhythmic principleE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1987
Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agentE M Vaughan Williams
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1975
Classification of antidysrhythmic drugsE M Vaughan Williams
Annals of the New York Academy of Sciences|January 1, 1984
DisopyramideE M Vaughan Williams
Journal of Clinical Pharmacology|April 1, 1984
A classification of antiarrhythmic actions reassessed after a decade of new drugsE M Vaughan Williams
Journal of Clinical Pharmacology|February 1, 1991
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trialE M Vaughan Williams
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmiasE M Vaughan Williams
Pageof 13